• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    87.21 1.15(1.34%) Dec 17, 4:00PM EST
    |After Hours : 87.20 Down 0.01 (0.01%) Dec 17, 7:37PM EST
    Add to Portfolio
    Prev Close:86.06
    Open:86.34
    Bid:84.50 x 200
    Ask:N/A
    1y Target Est:102.47
    Beta:1.16
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:85.72 - 87.83
    52wk Range:55.04 - 96.36
    Volume:1,575,123
    Avg Vol (3m):1,205,200
    Market Cap:12.86B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BMRN

    Comparison

    Symbol% ChgMkt Cap
    BMRNUp 1.34%12.86B
    FOLD621.08M
    SHPG42.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.05
    Quarterly EPS Est (Dec-14) :-0.60
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-3.32

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback